Ex-vivo gene therapy of diabetes using iap polypeptides
CA 2472333 A1 · Owner: Korneluk, Robert G. · Inventors: Verchere, Bruce; Liston, Peter; Tan, Rusung
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention features methods for the treatment of diabetes by administering a IAP nucleic acid sequence to a subject. One methodincludes the steps of. (a) providing one or more insulin-producing cells or one or more precursor cells capable of producing progeny cells tha tproduce insulin; (b) transducing the cells with a nucleic acid sequence encoding an IAP plypeptide the nucleic , acid sequence postioned for expression of the IAP polypeptide in the cells wherein expression of the IAP polypeptide increases survival of the cells relative to untreated control cells; and (c)transplanting the cells from step (b) that have been transduced with anucleic acid sequence encoding an IAP …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 23, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended January 23, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 23, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.